Safety Observations With 3 Years of Denosumab Exposure: Comparison Between Subjects Who Received Denosumab During the Randomized FREEDOM Trial and Subjects Who Crossed Over to Denosumab During the FREEDOM Extension

Author(s):
Watts, N.B.; Brown, J.P.; Papapoulos, S.; Lewiecki, E.M.; Kendler, D.L.; Dakin, P.; Wagman, R.B.; Wang, A.; Daizadeh, N.S.; Smith, S.; Bone, H.G.
Published
2017
Publication type
Article / Letter to editor
DENOSUMABPROLIASAFETYOSTEOPOROSISFRACTURE
Date issued
2017-07-31
Language
English
Is part of
Journal of Bone and Mineral Research (2017), Vol. 32, no. 7, p. 1481-1485
hdl
1887/94863
doi
10.1002/jbmr.3119